Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
746 articles
Scoping review reveals gap between research on aging interventions and actual implementation of WHO age-friendly frameworks in Malaysia.
Research outlines four priorities for creating healthier urban environments that could improve longevity outcomes for billions.
48-week study finds low-dose rapamycin safe with improvements in muscle mass and pain for women, but no major changes in body fat.
Comprehensive review explores how immunotherapy modalities can improve quality of life and extend lifespan across diverse conditions.
Meta-analysis of 65 studies reveals quercetin's powerful effects on skin aging, wound healing, and protection against oxidative damage.
Review identifies taurine, betaine, α-ketoglutarate, and other naturally-produced compounds that may delay aging through multiple cellular pathways.
New research shows biological age markers can guide personalized aesthetic treatments that target aging at the molecular level.
Comprehensive review reveals how immunosenescence creates tumor-promoting environments and reduces treatment effectiveness in elderly cancer patients.
Comprehensive review examines rapamycin's anti-aging potential, revealing mixed results and significant safety considerations for off-label use.
New review examines senolytic drugs that target aging cells in bone tissue, revealing gaps between promising animal studies and human trials.
New review reveals how senescent cells both prevent and fuel cancer, opening doors to precision therapies targeting aging pathways.
Comprehensive review reveals how drugs that eliminate or modify senescent cells could revolutionize anti-aging medicine.
